ID   MP2K6_HUMAN             Reviewed;         334 AA.
AC   P52564;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   05-OCT-2010, entry version 109.
DE   RecName: Full=Dual specificity mitogen-activated protein kinase kinase 6;
DE            Short=MAP kinase kinase 6;
DE            Short=MAPKK 6;
DE            EC=2.7.12.2;
DE   AltName: Full=MAPK/ERK kinase 6;
DE            Short=MEK 6;
DE   AltName: Full=SAPKK3;
GN   Name=MAP2K6; Synonyms=MEK6, MKK6, PRKMK6;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND MUTAGENESIS.
RC   TISSUE=Skeletal muscle;
RX   MEDLINE=96182129; PubMed=8622669;
RA   Raingeaud J., Whitmarsh A.J., Barrett T., Derijard B., Davis R.J.;
RT   "MKK3- and MKK6-regulated gene expression is mediated by the p38
RT   mitogen-activated protein kinase signal transduction pathway.";
RL   Mol. Cell. Biol. 16:1247-1255(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=T-cell;
RX   MEDLINE=96212215; PubMed=8626699; DOI=10.1074/jbc.271.19.11427;
RA   Stein B., Brady H., Yang M.X., Young D.B., Barbosa M.S.;
RT   "Cloning and characterization of MEK6, a novel member of the mitogen-
RT   activated protein kinase kinase cascade.";
RL   J. Biol. Chem. 271:11427-11433(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), TISSUE SPECIFICITY, AND
RP   MUTAGENESIS.
RC   TISSUE=Placenta;
RX   MEDLINE=96216353; PubMed=8621675; DOI=10.1074/jbc.271.6.2886;
RA   Han J., Lee J.-D., Jiang Y., Li Z., Feng L., Ulevitch R.J.;
RT   "Characterization of the structure and function of a novel MAP kinase
RT   kinase (MKK6).";
RL   J. Biol. Chem. 271:2886-2891(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   MEDLINE=96278799; PubMed=8663074; DOI=10.1074/jbc.271.23.13675;
RA   Moriguchi T., Kuroyanagi N., Yamaguchi K., Gotoh Y., Irie K., Kano T.,
RA   Shirakabe K., Muro Y., Shibuya H., Matsumoto K., Nishida E.,
RA   Hagiwara M.;
RT   "A novel kinase cascade mediated by mitogen-activated protein kinase
RT   kinase 6 and MKK3.";
RL   J. Biol. Chem. 271:13675-13679(1996).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   MEDLINE=97015116; PubMed=8861944;
RA   Cuenda A., Alonso G., Morrice N., Jones M., Meier R., Cohen P.,
RA   Nebreda A.R.;
RT   "Purification and cDNA cloning of SAPKK3, the major activator of
RT   RK/p38 in stress- and cytokine-stimulated monocytes and epithelial
RT   cells.";
RL   EMBO J. 15:4156-4164(1996).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Urinary bladder;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   CLEAVAGE BY ANTHRAX LETHAL FACTOR.
RX   MEDLINE=20558083; PubMed=11104681; DOI=10.1042/0264-6021:3520739;
RA   Vitale G., Bernardi L., Napolitani G., Mock M., Montecucco C.;
RT   "Susceptibility of mitogen-activated protein kinase kinase family
RT   members to proteolysis by anthrax lethal factor.";
RL   Biochem. J. 352:739-745(2000).
RN   [8]
RP   ACETYLATION AT SER-207 AND THR-211, PHOSPHORYLATION AT SER-207 AND
RP   THR-211, INACTIVATION BY YERSINIA YOPJ, AND MASS SPECTROMETRY.
RX   PubMed=16728640; DOI=10.1126/science.1126867;
RA   Mukherjee S., Keitany G., Li Y., Wang Y., Ball H.L., Goldsmith E.J.,
RA   Orth K.;
RT   "Yersinia YopJ acetylates and inhibits kinase activation by blocking
RT   phosphorylation.";
RL   Science 312:1211-1214(2006).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-28, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RA   Colinge J., Superti-Furga G., Bennett K.L.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-27; THR-28 AND SER-207,
RP   AND MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-82, AND MASS SPECTROMETRY.
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
CC   -!- FUNCTION: Catalyzes the concomitant phosphorylation of a threonine
CC       and a tyrosine residue in MAP kinase p38 exclusively.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ENZYME REGULATION: Probably activated by dual phosphorylation on
CC       Ser-207 and Thr-211.
CC   -!- SUBUNIT: Interacts with Yersinia yopJ.
CC   -!- INTERACTION:
CC       Q16512:PKN1; NbExp=1; IntAct=EBI-448135, EBI-602382;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=MKK6b;
CC         IsoId=P52564-1; Sequence=Displayed;
CC       Name=2; Synonyms=MKK6;
CC         IsoId=P52564-2; Sequence=VSP_004882;
CC   -!- TISSUE SPECIFICITY: Isoform 2 is only expressed in skeletal
CC       muscle. Isoform 1 is expressed in skeletal muscle, heart, and in
CC       lesser extent in liver or pancreas.
CC   -!- INDUCTION: Strongly activated by UV, anisomycin, and osmotic shock
CC       but not by phorbol esters, NGF or EGF.
CC   -!- PTM: Weakly autophosphorylated.
CC   -!- PTM: Acetylation of Ser-207 and Thr-211 by Yersinia yopJ prevents
CC       phosphorylation and activation, thus blocking the MAPK signaling
CC       pathway.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. MAP kinase kinase subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U39657; AAC50389.1; -; mRNA.
DR   EMBL; U39656; AAC50388.1; -; mRNA.
DR   EMBL; U49732; AAB05035.1; -; mRNA.
DR   EMBL; U39065; AAB03705.1; -; mRNA.
DR   EMBL; U39064; AAB03708.1; -; mRNA.
DR   EMBL; D87905; BAA13496.1; -; mRNA.
DR   EMBL; X96757; CAA65532.1; -; mRNA.
DR   EMBL; BC012009; AAH12009.1; -; mRNA.
DR   IPI; IPI00003814; -.
DR   IPI; IPI00219569; -.
DR   PIR; S71631; S71631.
DR   RefSeq; NP_002749.2; -.
DR   UniGene; Hs.463978; -.
DR   PDB; 3ENM; X-ray; 2.35 A; A/B/C/D=45-332.
DR   PDB; 3FME; X-ray; 2.26 A; A=47-334.
DR   PDBsum; 3ENM; -.
DR   PDBsum; 3FME; -.
DR   ProteinModelPortal; P52564; -.
DR   SMR; P52564; 9-316.
DR   DIP; DIP-31346N; -.
DR   IntAct; P52564; 5.
DR   MINT; MINT-3019559; -.
DR   STRING; P52564; -.
DR   PhosphoSite; P52564; -.
DR   PRIDE; P52564; -.
DR   Ensembl; ENST00000359094; ENSP00000351997; ENSG00000108984.
DR   GeneID; 5608; -.
DR   KEGG; hsa:5608; -.
DR   UCSC; uc002jij.1; human.
DR   CTD; 5608; -.
DR   GeneCards; GC17P067410; -.
DR   H-InvDB; HIX0017658; -.
DR   HGNC; HGNC:6846; MAP2K6.
DR   HPA; CAB007744; -.
DR   HPA; HPA031134; -.
DR   MIM; 601254; gene.
DR   PharmGKB; PA30591; -.
DR   eggNOG; prNOG16356; -.
DR   HOGENOM; HBG755340; -.
DR   HOVERGEN; HBG108518; -.
DR   InParanoid; P52564; -.
DR   OMA; ESAVAMV; -.
DR   OrthoDB; EOG9Q87GM; -.
DR   PhylomeDB; P52564; -.
DR   BRENDA; 2.7.12.2; 247.
DR   Pathway_Interaction_DB; anthraxpathway; Cellular roles of Anthrax toxin.
DR   Pathway_Interaction_DB; il1pathway; IL1-mediated signaling events.
DR   Pathway_Interaction_DB; il12_2pathway; IL12-mediated signaling events.
DR   Pathway_Interaction_DB; il6_7pathway; IL6-mediated signaling events.
DR   Pathway_Interaction_DB; p38_mkk3_6pathway; p38 MAPK signaling pathway.
DR   Pathway_Interaction_DB; ar_tf_pathway; Regulation of Androgen receptor activity.
DR   Pathway_Interaction_DB; p38alphabetapathway; Regulation of p38-alpha and p38-beta.
DR   Pathway_Interaction_DB; p38gammadeltapathway; Signaling mediated by p38-gamma and p38-delta.
DR   Pathway_Interaction_DB; mapktrkpathway; Trk receptor signaling mediated by the MAPK pathway.
DR   Reactome; REACT_21303; Myogenesis.
DR   Reactome; REACT_6900; Signaling in Immune system.
DR   NextBio; 21798; -.
DR   PMAP-CutDB; P52564; -.
DR   ArrayExpress; P52564; -.
DR   Bgee; P52564; -.
DR   CleanEx; HS_MAP2K6; -.
DR   Genevestigator; P52564; -.
DR   GermOnline; ENSG00000108984; Homo sapiens.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004708; F:MAP kinase kinase activity; TAS:ProtInc.
DR   GO; GO:0005515; F:protein binding; IPI:IntAct.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0007050; P:cell cycle arrest; TAS:ProtInc.
DR   GO; GO:0006975; P:DNA damage induced protein phosphorylation; TAS:ProtInc.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Complete proteome; Kinase; Nucleotide-binding; Phosphoprotein;
KW   Serine/threonine-protein kinase; Transferase; Tyrosine-protein kinase.
FT   CHAIN         1    334       Dual specificity mitogen-activated
FT                                protein kinase kinase 6.
FT                                /FTId=PRO_0000086386.
FT   DOMAIN       53    314       Protein kinase.
FT   NP_BIND      59     67       ATP (By similarity).
FT   ACT_SITE    179    179       Proton acceptor (By similarity).
FT   BINDING      82     82       ATP (By similarity).
FT   SITE         14     15       Cleavage; by anthrax lethal factor.
FT   MOD_RES      27     27       Phosphoserine.
FT   MOD_RES      28     28       Phosphothreonine.
FT   MOD_RES      82     82       N6-acetyllysine.
FT   MOD_RES     207    207       O-acetylserine; by Yersinia yopJ;
FT                                alternate.
FT   MOD_RES     207    207       Phosphoserine; alternate.
FT   MOD_RES     211    211       O-acetylthreonine; by Yersinia yopJ;
FT                                alternate.
FT   MOD_RES     211    211       Phosphothreonine; alternate.
FT   VAR_SEQ       1     56       Missing (in isoform 2).
FT                                /FTId=VSP_004882.
FT   MUTAGEN     207    207       S->A: Inactivation.
FT   MUTAGEN     207    207       S->E: Constitutive activation according
FT                                to PubMed:8622669, but not to
FT                                PubMed:8621675.
FT   MUTAGEN     211    211       T->A: Inactivation.
FT   MUTAGEN     211    211       T->E: Constitutive activation according
FT                                to PubMed:8622669, but not to
FT                                PubMed:8621675.
FT   CONFLICT    125    125       V -> M (in Ref. 3; AAB03705/AAB03708).
FT   HELIX        50     52
FT   STRAND       53     58
FT   STRAND       67     72
FT   STRAND       78     84
FT   HELIX        90    104
FT   STRAND      125    130
FT   STRAND      133    135
FT   HELIX       136    145
FT   TURN        152    154
FT   HELIX       158    172
FT   HELIX       182    184
FT   STRAND      193    196
FT   HELIX       222    225
FT   HELIX       236    242
FT   HELIX       246    252
FT   HELIX       263    272
FT   TURN        280    282
FT   HELIX       285    294
FT   HELIX       299    301
FT   HELIX       305    308
FT   HELIX       312    319
FT   HELIX       324    331
SQ   SEQUENCE   334 AA;  37492 MW;  4ECA8014522216AF CRC64;
     MSQSKGKKRN PGLKIPKEAF EQPQTSSTPP RDLDSKACIS IGNQNFEVKA DDLEPIMELG
     RGAYGVVEKM RHVPSGQIMA VKRIRATVNS QEQKRLLMDL DISMRTVDCP FTVTFYGALF
     REGDVWICME LMDTSLDKFY KQVIDKGQTI PEDILGKIAV SIVKALEHLH SKLSVIHRDV
     KPSNVLINAL GQVKMCDFGI SGYLVDSVAK TIDAGCKPYM APERINPELN QKGYSVKSDI
     WSLGITMIEL AILRFPYDSW GTPFQQLKQV VEEPSPQLPA DKFSAEFVDF TSQCLKKNSK
     ERPTYPELMQ HPFFTLHESK GTDVASFVKL ILGD
//
